New Cancer Biotherapeutics Conference in London - Call for Papers

 
NEEDHAM, Mass. - Sept. 10, 2015 - PRLog -- Following the success of the flagship PEGS Boston and PEGS Europe, and in response to the very exciting recent developments in cancer research, Cambridge Healthtech Institute (CHI) is pleased to announce a new three-day event on Cancer Biotherapeutics. Taking place 14-16 March 2016 in the vibrant London Docklands, Cancer Biotherapeutics will consist of two back-to-back conference programs, dinner courses and a dedicated exhibit hall.

Speaking proposals are now being accepted. To submit a proposed presentation, please visit http://cancerbiotherapeutics.com.

The first conference program on Immuno-Oncology will focus on innovations and progress in harnessing the body's immune response to attack cancer and on overcoming inhibitory factors that prevent this. Coverage will include research and case studies on modes of action, optimisation of specificity and potency, means of overcoming challenges such as short half-life and stability, results from the clinic, and evidence for a good durable response.

The following program, Novel Approaches for Cancer, focuses on engineering and development of biotherapeutics for cancer including synergistic combination approaches. It will cover bispecifics, ADCs, Fc engineering, fusion proteins and additional novel approaches. Presentations will include platform development, engineering challenges, MOA, and reasons for choice of target. In addition, CHI welcomes proposals on expression levels, affinity binding and optimisation of product properties such as and half-life, stability, manufacturability and scalability.

CHI brings you the highest standard of scientific content and collaboration with more than 130 conferences across the globe, include the industry leading PEGS: Essential Protein Engineering Summits, held each year in North America, Europe and Asia.

To learn more about CHI's Inaugural Cancer Biotherapeutics, please visit http://cancerbiotherapeutics.com.

Members of the media are encouraged to participate. Please contact Lisa Scimemi at lscimemi@healthtech.com to apply for a press pass and to inquire about opportunities for coordinated pre-event interviews with speaking faculty.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation and Cambridge Healthtech Media Group, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.

Contact
Cambridge Healthtech Institute
***@healthtech.com
End
Source: » Follow
Email:***@healthtech.com Email Verified
Tags:Cancer Research, Immunotherapy, Cancer Biologics
Industry:Biotech
Location:Needham - Massachusetts - United States
Subject:Websites
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share